Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

EPA/VIRP stock hub

EPA/VIRP has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EPA/VIRPis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.1B

Euronext Paris

Market data

Live price

Current market quote for this ticker.

Current price

EPA/VIRP

In the news

Latest news · EPA/VIRP

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E17.3

P25 n/aP50 n/aP75 n/a

Trailing P/E20.3

P25 n/aP50 n/aP75 n/a

ROE13.9

P25 n/aP50 n/aP75 n/a

ROIC12.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EPA/VIRP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

248

Groups with data

Currency

EUR

Showing 248 of 248 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	FR
Employees	6,442
Employees Change	77%
Employees Change Percent	1.21
Enterprise value	EUR 3.2B
Exchange	Euronext Paris
Financial currency	EUR
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	FR0000031577
Last refreshed	2026-05-10
Market cap	EUR 3.1B
Price	EUR 365
Price currency	EUR
Rev Per Employee	227,363.71x
Sector	Healthcare
Sic	2836
Symbol	epa/VIRP
Website	https://corporate.virbac.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.94%
EV Earnings	21.32x
EV/EBIT	13.97x
EV/EBITDA	11.03x
EV/FCF	30.13x
EV/Sales	2.2x
FCF yield	3.5%
Forward P/E	17.3x
P/B ratio	2.71x
P/E ratio	20.25x
P/S ratio	2.08x
PE Ratio10 Y	20.54x
PE Ratio3 Y	19.48x
PE Ratio5 Y	20.13x
PEG ratio	2.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	15.71%
EBITDA Margin	19%
FCF margin	7.29%
Gross margin	66.68%
Gross Profit	EUR 976.7M
Gross Profit Growth	2.18%
Gross Profit Growth Q	4.55%
Gross Profit Growth3 Y	3.04%
Gross Profit Growth5 Y	4.13%
Net Income	EUR 150.9M
Net Income Growth	3.85%
Net Income Growth Q	35.27%
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Net Income Growth3 Y	2.24%
Net Income Growth5 Y	4.83%
Pretax Margin	14.86%
Profit Margin	10.3%
Profit Per Employee	EUR 23,422
Profitable Years	8
ROA	7.65
Roa5y	8.57
ROCE	16.46
ROE	13.88
Roe5y	14.98
ROIC	12.35
Roic5y	16.45

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	9.76%
Cagr15y	7.84%
Cagr1y	19.36%
Cagr20y	11.49%
Cagr3y	7.77%
Cagr5y	6.84%
Div CAGR10	6.81%
Div CAGR3	3.18%
Div CAGR5	14.09%
EPS Growth	3.81
EPS Growth Q	35.17
EPS Growth Quarters	1
EPS Growth Years	2
EPS Growth3 Y	2.31
EPS Growth5 Y	5.02
FCF Growth	-20.91%
FCF Growth Q	6.71%
FCF Growth3 Y	5.37%
FCF Growth5 Y	3.13%
OCF Growth	-2.56%
OCF Growth Q	2.22%
OCF Growth10 Y	5.28%
OCF Growth3 Y	12.78%
OCF Growth5 Y	9.08%
Revenue Growth	4.82x
Revenue Growth Q	4.6x
Revenue Growth Quarters	5x
Revenue Growth Years	5x
Revenue Growth3 Y	3.03x
Revenue Growth5 Y	3.89x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.78
Assets	EUR 1.9B
Cash	EUR 126.2M
Current Assets	EUR 791.9M
Current Liabilities	EUR 516.3M
Debt	EUR 289.6M
Debt EBITDA	EUR 0.99
Debt Equity	EUR 0.26
Debt FCF	EUR 2.71
Equity	EUR 1.1B
Interest Coverage	26.05
Liabilities	EUR 789.2M
Long Term Assets	EUR 1.1B
Long Term Liabilities	EUR 272.9M
Net Cash	EUR -163.5M
Net Cash By Market Cap	EUR -5.35
Net Debt EBITDA	EUR 0.59
Net Debt Equity	EUR 0.15
Net Debt FCF	EUR 1.53
Tangible Book Value	EUR 538.1M
Tangible Book Value Per Share	EUR 64.22
WACC	7.91

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.53
Inventory Turnover	1.25
Net Working Capital	EUR 264.9M
Quick ratio	0.77
Working Capital	EUR 275.6M
Working Capital Turnover	EUR 4.47

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.06%
Dividend Growth	9.85%
Dividend Growth Years	1%
Dividend per share	EUR 1.45
Dividend Years	5
Dividend Yield	0.4%
Ex Div Date	2025-06-24
Last Dividend	EUR 1.45
Payout Frequency	Annual
Payout Ratio	8.05%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	153.67%
1Y total return	19.34%
200-day SMA	347.5
3Y total return	25.19%
50-day SMA	357.8
50-day SMA vs 200-day SMA	50over200
5Y total return	39.19%
All Time High	448.5
All Time High Change	-18.73%
All Time High Date	2021-11-01
All Time Low	8.01
All Time Low Change	4,449.43%
All Time Low Date	1992-01-02
ATR	8.55
Beta	0.77
Beta1y	0.63
Beta2y	0.66
Ch YTD	1.96
High	372
High52	389.5
High52 Date	2026-04-17
High52ch	-6.42%
Low	362.5
Low52	296
Low52 Date	2025-09-15
Low52ch	23.14%
Ma50ch	1.86%
Price vs 200-day SMA	4.89%
RSI	49.18
RSI Monthly	55.52
RSI Weekly	53.51
Sharpe ratio	0.65x
Sortino ratio	1.46
Total Return	0.34%
Tr YTD	1.96
Tr15y	210.1%
Tr1m	4.89%
Tr1w	0.55%
Tr3m	3.99%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 230.1M
Operating Income Growth	8.42
Operating Income Growth Q	22.36
Operating Income Growth3 Y	0.42
Operating Income Growth5 Y	5.49
Operating margin	15.71

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,125,190%
Net Borrowing	6,617,000
Shares Insiders	50.18%
Shares Institutions	21.03%
Shares Out	8,377,824
Shares Qo Q	0.12%
Shares Yo Y	0.06%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 106.8M
Average Volume	3,826.3x
Bv Per Share	134.3
CAPEX	EUR -92.2M
Ch10y	148.8
Ch15y	186.4
Ch1m	4.89
Ch1w	0.55
Ch1y	18.81
Ch20y	646.9
Ch3m	3.99
Ch3y	23.56
Ch5y	36.52
Ch6m	5.65
Change	-1.49%
Change From Open	-1.49
Close	370
Days Gap	0
Depreciation Amortization	48,122,000
Dollar Volume	1,035,180
Earnings Date	2026-09-17
EBIT	EUR 230.1M
EBITDA	EUR 278.3M
EPS	EUR 18
F Score	5
FCF	EUR 106.8M
FCF EV Yield	3.32x
FCF Per Share	EUR 12.74
Financing CF	-9,803,000
Fiscal Year End	December
Founded	1,968
Goodwill	356,055,000
Graham Number	233.22485
Graham Upside	-36.02
Income Tax	EUR 67.2M
Investing CF	-198,629,000
Is Primary Listing	1
Last Earnings Date	2025-09-12
Last Report Date	2025-12-31
Last Split Date	2002-07-30
Last Split Type	Forward
Lynch Fair Value	EUR 90
Lynch Upside	-75.31
Ma150	353.4
Ma150ch	3.14%
Ma20	369.9
Ma20ch	-1.45%
Net CF	-24,739,000
Next Earnings Date	2026-09-17
Open	370
P FCF Ratio	28.61
P OCF Ratio	15.35
Payment Date	2025-06-26
Position In Range	21.05
Ppne	461,752,000
Price Date	2026-05-08
Price EBITDA	EUR 10.97
Ptbv Ratio	5.68
Relative Volume	0.74x
Revenue	1,464,677,000x
Tax By Revenue	4.59x
Tax Rate	30.89%
Tr20y	781.13%
Tr6m	5.65%
Volume	2,840
Z Score	3.52

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

EPA/VIRP dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.4%

$1.45 annual per share

Payout ratio

+8.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+14.1%

1 consecutive years of growth

Total shareholder yield

+0.3%

Next ex-dividend date: 2025-06-24

Performance

EPA/VIRP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns EPA/VIRP?

Insider, institutional, and short-interest positioning.

Institutional ownership

+21.0%

Share of float held by funds and institutions

Insider ownership

+50.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

EPA/VIRP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.2

Neutral momentum band

Price vs 200-day MA

+4.9%

50/200-day relationship not available

Beta (5Y)

0.77

Less volatile than the market

Sharpe ratio

0.65

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EPA/VIRP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current epa/VIRP stock rating?

epa/VIRP is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full epa/VIRP analysis?

The full report lives at /stocks/epa/VIRP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for epa/VIRP?

The latest report frames epa/VIRP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the epa/VIRP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.